The PFA-100® detects sub-optimal antiplatelet responses in patients on aspirin

By Sambola A.   Heras M.   Escolar G.   Lozano M.   Pino M.   Martorell T.   Torra M.   Sanz G.  

Platelets, Vol. 15, Iss. 7, 2004-11 ,pp. : 439-446

Informa Healthcare

Access to resources Recommend Favorite

Comparison of turbidimetric aggregation and in vitro bleeding time (PFA-100) for monitoring the platelet inhibitory profile of antiplatelet agents in patients undergoing stent implantation

By Van der Planken M.G.   Claeys M.J.   Vertessen F.J.   Dilling D.   Bosmans J.M.   Berneman Z.N.   Michiels J.J.   Vrints C.  

Thrombosis Research, Vol. 111, Iss. 3, 2003-01 ,pp. : 159-164

Elsevier

Access to resources Recommend Favorite

PFA-100&unknown; and flow cytometry: can they challenge aggregometry to assess antiplatelet agents, other than GPIIbIIIa blockers, in coronary angioplasty?

By Hezard N.   Metz D.   Nazeyrollas P.   Droulle C.   Potron G.   Nguyen P.  

Thrombosis Research, Vol. 108, Iss. 1, 2002-10 ,pp. : 43-47

Elsevier

Access to resources Recommend Favorite

Clopidogrel anti-platelet effect: An evaluation by optical aggregometry, impedance aggregometry, and the Platelet Function Analyzer (PFA-100™)

By Dyszkiewicz-Korpanty Anna   Olteanu Horatiu   Frenkel Eugene   Sarode Ravindra  

Platelets, Vol. 18, Iss. 7, 2007-11 ,pp. : 491-496

Informa Healthcare

Access to resources Recommend Favorite

Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease

By Andersen K.   Hurlen M.   Arnesen H.   Seljeflot I.  

Thrombosis Research, Vol. 108, Iss. 1, 2002-10 ,pp. : 37-42

Elsevier

Access to resources Recommend Favorite